Systemic Anti-Cancer Drug Programme

A Systemic Anti-Cancer Drug Programme (also known as a Chemotherapy Programme) is an Anti-Cancer Drug Programme, which is a CLINICAL INTERVENTION

A Systemic Anti-Cancer Drug Programme is the pre-planned sequence of treatment of Chemotherapy that may include one or more Systemic Anti-Cancer Drug Regimens.

If the PATIENT’s clinical situation changes, then subsequent treatment constitutes a new Systemic Anti-Cancer Drug Programme

For example, a PATIENT may receive four months of a taxane drug, the disease is thought to have stabilised and the treatment is stopped.  Two months later progressive disease is identified and the PATIENT is started on the Capecitabine drug, this constitutes a new Systemic Anti-Cancer Drug Programme.

For example, where a PATIENT remains continuously on Chemotherapy for a prolonged period, having a sequence of palliative regimens each in an attempt to control disease this would constitute a series of Systemic Anti-Cancer Drug Programmes, as it was not a planned sequence.

Note: In the management of the majority of adult solid tumours, the Chemotherapy Programme and Chemotherapy Regimen will be the same.  Particularly in the management of haematological and paediatric tumours, two or more recognised Chemotherapy Regimens may be given concurrently or sequentially and constitute a single Chemotherapy Programme.

 

This supporting information is also known by these names:
ContextAlias
alsoknownasChemotherapy Programme
pluralSystemic Anti-Cancer Drug Programmes